Navigation Links
Phase II Data on Lilly's Antibody Show It Affects Amyloid Beta, a Protein Believed To Be Associated with Alzheimer's Disease
Date:7/30/2008

venth-leading cause of death in the United States(4). The direct and indirect health care costs associated with Alzheimer's disease in the U.S. are estimated to be about $150 billion(5). In 2005, the total cost worldwide was estimated at $315.4 billion(6).

Given the aging population, without the availability of medicines that delay or prevent the onset of Alzheimer's disease, the number of affected people worldwide is expected to quadruple by the year 2050(7). The average duration between onset of symptoms and death due to complications of Alzheimer's disease is about 8-10 years(8). The burden to caregivers and health care costs can increase dramatically in the late stages of Alzheimer's disease, when patients cannot maintain independent function and are frequently bedridden.

About LY2062430

LY2062430 binds specifically to soluble amyloid beta and thereby alters the sticky characteristics of this peptide. Alzheimer's disease theory suggests that amyloid beta kills brain cells. Clinical studies have examined the ability of LY2062430 to impact amyloid beta in blood and cerebrospinal fluid and found significant dose-dependent changes. To date, the most frequently occurring side effect experienced in clinical studies with LY2062430 has been mild chills consistent with an infusion reaction. For a more complete listing of potential side effects, prospective clinical trial participants should refer to the informed consent document.

About Lilly

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers -- through medicines and information -- for some of the world's most urgent medical needs. Additional information about Lilly is available at

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2008)... Abnormalities in audito...ldren with autism spectrum disorder by using magne...ented today at the annual meeting of the Radiologi...sing MEG, we can record the tiny magnetic fields a...mothy Roberts, Ph.D., vice chair of research in th...
(Date:11/28/2008)...v. 28 Eli Lilly and Comp... New Drug Application (sNDA) from,the U.S. Food a...xetine HCl),for the management of chronic pain. L...st half of 2009, adding data from a recently compl...n of the knee. , The decision does not affe...
(Date:11/26/2008)..., Nov. 26 Children whos...nificantly increased risk of developing mental ill... a Mayo Clinic study published this month in Pedia...my of Pediatrics. , , The retrospective stu...th strabismus (misaligned eyes) and compared them ...
(Date:11/26/2008)...o 406 Subjects , , FRANKLIN, Mass., Nov. 26...ulletin Board: PLCSF) announced today that it has ... Administration (FDA) for its U.S. pivotal trial t...ard System(TM) and associated therapy in the prev... , The FDA also approved PLC,s request to expa...
Breaking Medicine Technology:Brain Waves Show Sound Processing Abnormalities in Autistic Children 2Brain Waves Show Sound Processing Abnormalities in Autistic Children 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4Eye Divergence in Children Triples Risk of Mental Illness 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4American Legacy Foundation Comments on New York State Department of Health Petition to the FDA to Expand Consumer Access to Over the Counter Nicotine 10264 1American Legacy Foundation Comments on New York State Department of Health Petition to the FDA to Expand Consumer Access to Over the Counter Nicotine 10264 2Regular marijuana use increases risk of hepatitis C related liver damage 10262 1Regular marijuana use increases risk of hepatitis C related liver damage 10262 2Regular marijuana use increases risk of hepatitis C related liver damage 10262 3CDC Report Highlights the Need for Safe Use and Safekeeping of Medicines 10260 1CDC Report Highlights the Need for Safe Use and Safekeeping of Medicines 10260 2ActivBiotics Completes Sale of Fixed Assets 3B Expands Due Diligence Initiative for the Sale of Intellectual Property Including Drug Product Candidat 2778 1
...ire/ -- MAP,Pharmaceuticals, Inc. today announced ...se Budesonide (UDB) pediatric asthma therapy,clini...fi Kirdar,Convention and Exhibition Center in Ista...ntitled, "Efficacy and safety,of a novel submicron...delivery in a 6 week study in 1-18 year old asthma...
... tumor lysate,triggers robust antigen-specific CTL..., June 22, 2007,/PRNewswire/ -- MaxCyte, Inc. and ...tion at the 13th Annual Meeting of the,Internation...ing,held June 24-27, 2007 in Sydney, Australia. , ...ture dendritic,cells with tumor lysate triggers ro...
Other Medicine Technology:MAP Pharmaceuticals to Present Unit Dose Budesonide Phase 2,Clinical Data at the World Asthma Meeting 2MaxCyte and Medinet to Present at the 13th Annual Meeting of the,International Society for Cellular Therapy (ISCT) in Sydney,Australia 2MaxCyte and Medinet to Present at the 13th Annual Meeting of the,International Society for Cellular Therapy (ISCT) in Sydney,Australia 3
(Date:12/1/2008)... a cold December day in,Memphis, Tennessee and Fe...amilo Villegas and LPGA star Morgan Pressel have g...s that has brought three of the biggest names in,...e important than any game of,golf -- children bat...m.com/cgi-bin/prnh/20081201/CLM117 ) , Sin...
(Date:12/1/2008)...n the face of one of the most,severe economic dow...Board of,Directors has approved an investment of ...tter Health Retirement Plan. Employee pension plan... bonds, have been among the biggest,casualties of...tively,invested, the Sutter Health Retirement Pla...
(Date:12/1/2008)... Westaim Corporation today announced it has requis...ST Pharmaceuticals Corp. to consider a return of c...$15 million or US$0.80 per share. Westaim will con... of its 74.5 per cent stake in NUCRYST. Under the ... of Directors has 20 days to call a meeting of sha...
(Date:12/1/2008)...HICON, Inc., a Johnson & Johnson company, anno...of its Professional Wound Care business to One Equ...are not being disclosed. , , Under the term...ired the Professional Wound Care product portfolio...s PROMOGRAN Matrix Wound Dressing, TIELLE Hydropol...
Breaking Medicine News(10 mins):Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 2Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 3Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 4Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 5Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 6Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 7Health News:Sutter Health Invests Hundreds of Millions in Employee Pension 2Health News:The Westaim Corporation requisitions meeting of shareholders of NUCRYST Pharmaceuticals to return capital to NUCRYST shareholders 2Health News:ETHICON Completes Divestiture of Professional Wound Care Business to One Equity Partners 2Health News:ETHICON Completes Divestiture of Professional Wound Care Business to One Equity Partners 3
... disease through causing inflammation of the arter... may set the scene for heart disease. A new study ...C - reactive protein (CRP). Researchers at the Uni...th gum disease have higher than normal CRP levels....
...the back of the mouth is successful in relieving s...of women have a problem with snoring - and it gets... the soft palate - the area of tissue at the back ...e tonsils, and the base of the tongue. Surgery tha...
...mproves the paralysis experienced by stroke surviv...opamine in the body, and this may help brain cells... normally. It's used as a treatment in Parkinson's...a is also helpful in alleviating stroke-induced di...
...gh School of Medicine found that a treatment progr... weight is the first treatment to significantly im... Previous interventions for weight-concerned women...ing cessation was to help them prevent any weight ...
Other Medicine News:Health News:Stop smoking and reduce weight 2
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
Medicine Products: